Patient diagnosed with an aggressive form of brain cancer became the first person in the US to access an experimental treatment under the Right to Try law of 2017. 

Right-to-try laws are U.S. state and Federal laws that were created to let terminally ill patients try ex...

In 2018 CDER approved 59 drugs. Eighteen of those were for cancer patients. CDER used a variety of expedited development and regulatory review tools to seed drugs to market. 

Click on the image to see full FDA report.

Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also are having a positive impact, experts say.

Click on image to see full article at AP.

I thought I'd share a non-healthcare, non-pharma link today. As the year comes to a close and we begin to reflect on how we spent our time, its natural to reflect on this idea of happiness. Am I happy? Do I pursue happiness. Check out this brief article and its simple...

FDA highlights approvals in 2018 at recent ASH meeting in San Diego. 2018 saw 32 FDA approvals in hematology including 12 NMEs & 5 biosimilars. 8 had pediatric indications. 6 were for 1st-line indications.

https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm27...

PhRMA released comprehensive report outlining emerging trends in cancer drug development. Over 1100 drugs and vaccines are being developed across all diseases. 

PhRMA released report on May 30, 2018, just days ahead of the big ASCO meeting in Chicago. 

Read the summ...

As tens of thousands of cancer professionals head off to Chicago for ASCO meeting this week, PHRMA releases new report outlining over 1100 drugs and vaccines in development.  

"America's biopharmaceutical companies are developing 1,100 medicines and vaccines for cancer,...

A new study recently published in Value in Health  by Risha Gidwani-Marszowski, DrPH, a health economist at the VA Palo Alto Health Care System and at Stanford.

Click image to read full article...

Personalized Medicine at FDA: 2017 Progress Report documents the record number of new personalized medicines the U.S. Food and Drug Administration (FDA) approved in 2017, the fourth consecutive year that personalized medicines accounted for more than 20 percent of all...

Please reload

Recent Posts
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square

info@oncologystrategies.com   |   Overland Park, KS 66223

  • Facebook Basic Black
  • Twitter Basic Black
  • Black Instagram Icon